Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $21.15 Consensus Price Target from Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned a consensus rating of “Hold” from the sixteen brokerages that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $22.1923.

A number of equities analysts have recently weighed in on ACHC shares. Barclays upped their price objective on Acadia Healthcare from $14.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 3rd. Leerink Partners upped their price target on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a research note on Thursday, February 26th. Guggenheim lowered their target price on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a report on Monday, February 23rd. Jefferies Financial Group restated a “hold” rating and set a $24.50 target price on shares of Acadia Healthcare in a research report on Monday. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Goldman Sachs Group Inc. raised its position in shares of Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after buying an additional 3,815,471 shares in the last quarter. Jefferies Financial Group Inc. bought a new stake in Acadia Healthcare during the fourth quarter worth approximately $47,960,000. Wellington Management Group LLP raised its position in Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the period. Vaughan Nelson Investment Management L.P. bought a new stake in shares of Acadia Healthcare in the 1st quarter valued at approximately $43,017,000. Finally, Invenomic Capital Management LP boosted its holdings in shares of Acadia Healthcare by 71.0% in the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after purchasing an additional 1,375,647 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $27.84 on Thursday. The company has a market capitalization of $2.56 billion, a P/E ratio of -2.28, a P/E/G ratio of 9.12 and a beta of 0.71. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $28.48. The firm’s 50 day simple moving average is $22.61 and its two-hundred day simple moving average is $19.02. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.55.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The firm had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. During the same period last year, the firm earned $0.64 EPS. The company’s revenue was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Research analysts expect that Acadia Healthcare will post 1.48 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.